ABCC5 and neoplasm: Although both tumor net weight and size decreased after ABCC5 knockdown or enzalutamide treatment alone, ABCC5 depletion combined with enzalutamide treatment showed a more significant inhibitory effect on xenograft tumor proliferation than enzalutamide alone (Fig. 4C).